| scholarly article | Q13442814 |
| P2093 | author name string | Rainer Kunstfeld | |
| Laura Desch | |||
| P2860 | cites work | Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 |
| Merkel cell carcinoma. | Q25257116 | ||
| Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor | Q27824804 | ||
| Merkel cell carcinoma: prognosis and treatment of patients from a single institution | Q28242597 | ||
| Merkel cell carcinoma: recent insights and new treatment options | Q28257160 | ||
| Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors | Q29618610 | ||
| Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults | Q33636436 | ||
| Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases | Q33944415 | ||
| Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens | Q33966574 | ||
| A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331) | Q34088836 | ||
| Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system | Q34208807 | ||
| Trabecular Carcinoma of the Skin | Q34226403 | ||
| Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. | Q34866209 | ||
| G3139 (Genasense) in patients with advanced merkel cell carcinoma | Q35029577 | ||
| A review of the epidemiology and treatment of Merkel cell carcinoma. | Q35232484 | ||
| Antibody targeted drugs as cancer therapeutics | Q36373103 | ||
| Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. | Q36585604 | ||
| Total spontaneous regression of advanced merkel cell carcinoma after biopsy: review and a new case. | Q37118052 | ||
| Management of Merkel tumours: an evidence-based review | Q37129549 | ||
| The etiology and epidemiology of merkel cell carcinoma | Q37725227 | ||
| Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature | Q37762413 | ||
| Remission of Merkel cell tumor after somatostatin analog treatment | Q37813950 | ||
| KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro | Q39653324 | ||
| Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): a case report | Q42905902 | ||
| CD117 (KIT receptor) expression in Merkel cell carcinoma | Q44079778 | ||
| High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07. | Q44674122 | ||
| Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. | Q44880020 | ||
| Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report | Q44892538 | ||
| c-kit expression in primary and metastatic merkel cell carcinoma | Q45201428 | ||
| New Virus Associated With Merkel Cell Carcinoma Development | Q45372804 | ||
| Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. | Q45947378 | ||
| Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy | Q46134137 | ||
| Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate | Q46812189 | ||
| Merkel cell carcinoma in a patient treated with adalimumab: case report. | Q46817363 | ||
| Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis | Q46847155 | ||
| KIT receptor (CD117) expression in Merkel cell carcinoma. | Q48011634 | ||
| [Merkel cell tumor or neuroendocrine skin carcinoma] | Q50903347 | ||
| Induction of durable responses by oral etoposide monochemotherapy in patients with metastatic Merkel cell carcinoma. | Q51368610 | ||
| Treatment of merkel cell carcinoma. | Q54363298 | ||
| Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. | Q55033112 | ||
| Merkel cell carcinoma and HIV infection. | Q55035696 | ||
| Merkel cell carcinoma | Q56681295 | ||
| Aktuelles Update zur Tumorbiologie und Behandlung des Merkelzell-Karzinoms | Q62268175 | ||
| Expression of vascular endothelial growth factor receptor-2 in Merkel cell carcinoma | Q62268270 | ||
| Treatment of Recurrent Merkel Cell Carcinoma: An Analysis of 46 Cases | Q63365744 | ||
| Chemotherapy of Disseminated Merkel-Cell Carcinoma | Q67929076 | ||
| Chemotherapy for metastatic Merkel cell carcinoma | Q70092226 | ||
| Small-cell neuroepithelial tumor of skin: a Merkel-cell neoplasm? | Q70289506 | ||
| Neuroendocrine (Merkel cell) carcinoma of the skin | Q70420437 | ||
| Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group | Q71067493 | ||
| Neuroendocrine (Merkel cell) carcinoma of the skin. A histologic and ultrastructural study of two cases | Q71255943 | ||
| Trabecular carcinoma of the skin: further clinicopathologic and morphologic study | Q71860896 | ||
| VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission | Q72073291 | ||
| Primary small cell carcinoma of the skin | Q72867775 | ||
| Early aggressive treatment for Merkel cell carcinoma improves outcome | Q73966702 | ||
| 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors | Q74789080 | ||
| Surgical management of Merkel cell carcinoma | Q77922711 | ||
| Expression profiles associated with aggressive behavior in Merkel cell carcinoma | Q79370590 | ||
| [Merkel cell carcinoma and sentinel lymph node dissection: nine cases report] | Q80638497 | ||
| Merkel cell carcinoma: treatment and outcomes | Q81149867 | ||
| Merkel cell carcinoma: improved outcome with adjuvant radiotherapy | Q81809123 | ||
| Rising incidence of Merkel cell carcinoma | Q83258390 | ||
| [Merkel cell carcinoma during treatment with TNF-alpha inhibitors: coincidence or warning?] | Q84248810 | ||
| Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus | Q84999289 | ||
| Short German guidelines: Merkel cell carcinoma | Q95820035 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | chemotherapy | Q974135 |
| Merkel cell carcinoma | Q1711744 | ||
| P304 | page(s) | 327150 | |
| P577 | publication date | 2013-02-10 | |
| P1433 | published in | Journal of Skin Cancer | Q26842488 |
| P1476 | title | Merkel cell carcinoma: chemotherapy and emerging new therapeutic options | |
| P478 | volume | 2013 |
| Q94465321 | A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients |
| Q38317279 | A case series and literature review of Merkel cell carcinoma metastasizing to pancreas |
| Q38378516 | Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial |
| Q88810010 | Avelumab: A Review in Metastatic Merkel Cell Carcinoma |
| Q64993029 | Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US. |
| Q35122235 | Gene expression differences predict treatment outcome of merkel cell carcinoma patients |
| Q98283428 | Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma |
| Q40289983 | Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma. |
| Q38855025 | Merkel Cell Carcinoma Therapeutic Update |
| Q64982129 | Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies. |
| Q34273863 | Merkel cell carcinoma dependence on bcl-2 family members for survival. |
| Q38114084 | Merkel cell carcinoma of left groin: a case report and literature review. |
| Q51012152 | Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. |
| Q26796421 | Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options |
| Q38682926 | Merkel cell carcinoma: Do you know your guidelines? |
| Q50060650 | Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy |
| Q38388671 | Neuroendocrine Merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case-based study using targeted massively parallel sequencing |
| Q52686466 | PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma. |
| Q28084788 | Risk of second cancers in merkel cell carcinoma: a meta-analysis of population based cohort studies |
| Q89208524 | Systematic review of sentinel lymph node biopsy in Merkel cell carcinoma of the head and neck |
| Q21129301 | The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature |
| Q64930981 | Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches. |
| Q38175499 | Update of cetuximab for non-melanoma skin cancer |
| Q85335650 | [Merkel cell carcinoma] |
Search more.